questionsmedicales.fr
Maladies du système nerveux
Maladies du système nerveux central
Encéphalopathies
Épilepsie
Syndromes épileptiques
Épilepsie temporale
Épilepsie temporale : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Épilepsie
Électroencéphalographie
Imagerie par résonance magnétique
Tests neuropsychologiques
Imagerie cérébrale
Épilepsie
Électroencéphalographie
Épilepsie
Anomalies cérébrales
Épilepsie
Crises épileptiques
Diagnostic différentiel
Épilepsie
Troubles de la mémoire
Comportements automatiques
Symptômes
5
Épilepsie
Hallucinations
Troubles de la mémoire
Crises épileptiques
Épilepsie
Variabilité des symptômes
Épilepsie
Signes avant-coureurs
Changements d'humeur
Épilepsie
Conscience
Crises épileptiques
Épilepsie
Crises focales
Convulsions
Prévention
5
Épilepsie
Prévention
Déclencheurs de crises
Épilepsie
Déclencheurs de crises
Stress
Éducation des patients
Épilepsie
Gestion de la maladie
Épilepsie
Activités physiques
Sécurité
Épilepsie
Suivi médical
Traitement
Traitements
5
Épilepsie
Médicaments antiépileptiques
Chirurgie épileptique
Épilepsie
Médicaments
Contrôle des crises
Chirurgie épileptique
Épilepsie
Traitement médical
Épilepsie
Effets secondaires
Médicaments antiépileptiques
Épilepsie
Diète cétogène
Thérapies alternatives
Complications
5
Épilepsie
Complications
Troubles psychologiques
Épilepsie
Dépression
Anxiété
Épilepsie
SUDEP
Complications
Épilepsie
Premiers secours
Sécurisation de l'environnement
Épilepsie
Troubles cognitifs
Mémoire
Facteurs de risque
5
Épilepsie
Facteurs de risque
Traumatismes crâniens
Épilepsie
Âge
Facteurs de risque
Épilepsie
Maladies neurologiques
Sclérose en plaques
Épilepsie
Stress
Facteurs de risque
Épilepsie
Infections cérébrales
Encéphalite
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Épilepsie temporale : Questions médicales les plus fréquentes",
"headline": "Épilepsie temporale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Épilepsie temporale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-15",
"dateModified": "2025-04-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Épilepsie temporale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Syndromes épileptiques",
"url": "https://questionsmedicales.fr/mesh/D000073376",
"about": {
"@type": "MedicalCondition",
"name": "Syndromes épileptiques",
"code": {
"@type": "MedicalCode",
"code": "D000073376",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.228.140.490.493"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Épilepsie temporale",
"alternateName": "Epilepsy, Temporal Lobe",
"code": {
"@type": "MedicalCode",
"code": "D004833",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Lorenzo Caciagli",
"url": "https://questionsmedicales.fr/author/Lorenzo%20Caciagli",
"affiliation": {
"@type": "Organization",
"name": "Department of Bioengineering, University of Pennsylvania, United States."
}
},
{
"@type": "Person",
"name": "Anna Rita Giovagnoli",
"url": "https://questionsmedicales.fr/author/Anna%20Rita%20Giovagnoli",
"affiliation": {
"@type": "Organization",
"name": "Department of Diagnostics and Applied Technology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy. Electronic address: annarita.giovagnoli@istituto-besta.it."
}
},
{
"@type": "Person",
"name": "Sjoerd B Vos",
"url": "https://questionsmedicales.fr/author/Sjoerd%20B%20Vos",
"affiliation": {
"@type": "Organization",
"name": "Centre for Microscopy, Characterisation, and Analysis, University of Western Australia, Nedlands, Australia."
}
},
{
"@type": "Person",
"name": "John S Duncan",
"url": "https://questionsmedicales.fr/author/John%20S%20Duncan",
"affiliation": {
"@type": "Organization",
"name": "Department of Epilepsy, UCL Queen Square Institute of Neurology, London, United Kingdom."
}
},
{
"@type": "Person",
"name": "Ali A Asadi-Pooya",
"url": "https://questionsmedicales.fr/author/Ali%20A%20Asadi-Pooya",
"affiliation": {
"@type": "Organization",
"name": "Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Jefferson Comprehensive Epilepsy Center, Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA. Electronic address: aliasadipooya@yahoo.com."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Progestins of today and tomorrow.",
"datePublished": "2022-08-19",
"url": "https://questionsmedicales.fr/article/36036464",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/GCO.0000000000000819"
}
},
{
"@type": "ScholarlyArticle",
"name": "Opposed evolution of the osseous and soft parts of progestin-associated osteomeningioma after progestin intake discontinuation.",
"datePublished": "2023-03-03",
"url": "https://questionsmedicales.fr/article/36883659",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3171/2022.12.JNS222006"
}
},
{
"@type": "ScholarlyArticle",
"name": "Systemic Progestins and Progestin-Releasing Intrauterine Device Therapy for Premenopausal Patients With Endometrial Intraepithelial Neoplasia.",
"datePublished": "2023-04-05",
"url": "https://questionsmedicales.fr/article/37023446",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/AOG.0000000000005124"
}
},
{
"@type": "ScholarlyArticle",
"name": "Efficacy of Low-Dose Estrogen-Progestins and Progestins in Japanese Women with Dysmenorrhea: A Systematic Review and Network Meta-analysis.",
"datePublished": "2022-09-01",
"url": "https://questionsmedicales.fr/article/36048405",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12325-022-02298-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Progestin plus metformin improves outcomes in patients with endometrial hyperplasia and early endometrial cancer more than progestin alone: a meta-analysis.",
"datePublished": "2023-06-21",
"url": "https://questionsmedicales.fr/article/37415671",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fendo.2023.1139858"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système nerveux",
"item": "https://questionsmedicales.fr/mesh/D009422"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies du système nerveux central",
"item": "https://questionsmedicales.fr/mesh/D002493"
},
{
"@type": "ListItem",
"position": 4,
"name": "Encéphalopathies",
"item": "https://questionsmedicales.fr/mesh/D001927"
},
{
"@type": "ListItem",
"position": 5,
"name": "Épilepsie",
"item": "https://questionsmedicales.fr/mesh/D004827"
},
{
"@type": "ListItem",
"position": 6,
"name": "Syndromes épileptiques",
"item": "https://questionsmedicales.fr/mesh/D000073376"
},
{
"@type": "ListItem",
"position": 7,
"name": "Épilepsie temporale",
"item": "https://questionsmedicales.fr/mesh/D004833"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Épilepsie temporale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Épilepsie temporale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Épilepsie temporale",
"description": "Comment diagnostiquer l'épilepsie temporale ?\nQuels tests sont utilisés pour l'évaluation ?\nL'EEG est-il toujours nécessaire ?\nPeut-on confondre avec d'autres types d'épilepsie ?\nQuels signes cliniques aident au diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D004833?mesh_terms=Progestins#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Épilepsie temporale",
"description": "Quels sont les symptômes courants ?\nLes crises sont-elles toujours similaires ?\nY a-t-il des signes avant-coureurs ?\nLes crises affectent-elles la conscience ?\nPeut-on avoir des crises sans convulsions ?",
"url": "https://questionsmedicales.fr/mesh/D004833?mesh_terms=Progestins#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Épilepsie temporale",
"description": "Peut-on prévenir les crises d'épilepsie temporale ?\nQuels sont les déclencheurs à éviter ?\nL'éducation est-elle importante ?\nLes activités physiques sont-elles sûres ?\nLe suivi médical est-il essentiel ?",
"url": "https://questionsmedicales.fr/mesh/D004833?mesh_terms=Progestins#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Épilepsie temporale",
"description": "Quels traitements sont disponibles ?\nLes médicaments sont-ils efficaces ?\nQuand envisager la chirurgie ?\nY a-t-il des effets secondaires aux traitements ?\nDes thérapies alternatives existent-elles ?",
"url": "https://questionsmedicales.fr/mesh/D004833?mesh_terms=Progestins#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Épilepsie temporale",
"description": "Quelles complications peuvent survenir ?\nL'épilepsie temporale augmente-t-elle les risques ?\nLes crises peuvent-elles être mortelles ?\nComment gérer les blessures liées aux crises ?\nLes troubles cognitifs sont-ils fréquents ?",
"url": "https://questionsmedicales.fr/mesh/D004833?mesh_terms=Progestins#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Épilepsie temporale",
"description": "Quels sont les facteurs de risque connus ?\nL'âge influence-t-il le risque d'épilepsie temporale ?\nLes maladies neurologiques augmentent-elles le risque ?\nLe stress peut-il être un facteur de risque ?\nLes infections peuvent-elles causer l'épilepsie temporale ?",
"url": "https://questionsmedicales.fr/mesh/D004833?mesh_terms=Progestins#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'épilepsie temporale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'EEG, l'IRM cérébrale et l'historique des crises."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour l'évaluation ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests neuropsychologiques et des examens d'imagerie sont souvent réalisés."
}
},
{
"@type": "Question",
"name": "L'EEG est-il toujours nécessaire ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'EEG est essentiel pour identifier les anomalies électriques cérébrales."
}
},
{
"@type": "Question",
"name": "Peut-on confondre avec d'autres types d'épilepsie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les crises temporales peuvent être confondues avec d'autres types de crises."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques aident au diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les troubles de la mémoire et les comportements automatiques sont des indicateurs."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des crises, des hallucinations et des troubles de la mémoire."
}
},
{
"@type": "Question",
"name": "Les crises sont-elles toujours similaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les crises peuvent varier en intensité et en durée d'une personne à l'autre."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes avant-coureurs ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des sensations étranges ou des changements d'humeur peuvent précéder les crises."
}
},
{
"@type": "Question",
"name": "Les crises affectent-elles la conscience ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines crises temporales peuvent entraîner une altération de la conscience."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des crises sans convulsions ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des crises focales peuvent survenir sans convulsions visibles."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les crises d'épilepsie temporale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par un traitement adéquat et l'évitement des déclencheurs."
}
},
{
"@type": "Question",
"name": "Quels sont les déclencheurs à éviter ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress, le manque de sommeil et l'alcool peuvent déclencher des crises."
}
},
{
"@type": "Question",
"name": "L'éducation est-elle importante ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation des patients et des proches aide à mieux gérer la maladie."
}
},
{
"@type": "Question",
"name": "Les activités physiques sont-elles sûres ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, mais il est important de choisir des activités adaptées et sécurisées."
}
},
{
"@type": "Question",
"name": "Le suivi médical est-il essentiel ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier permet d'ajuster le traitement et de surveiller les progrès."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments antiépileptiques et parfois la chirurgie."
}
},
{
"@type": "Question",
"name": "Les médicaments sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreux patients contrôlent leurs crises avec des médicaments appropriés."
}
},
{
"@type": "Question",
"name": "Quand envisager la chirurgie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est envisagée si les médicaments échouent à contrôler les crises."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires aux traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les médicaments peuvent avoir des effets secondaires comme la somnolence."
}
},
{
"@type": "Question",
"name": "Des thérapies alternatives existent-elles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines thérapies comme la diète cétogène peuvent aider certains patients."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des blessures lors des crises et des troubles psychologiques."
}
},
{
"@type": "Question",
"name": "L'épilepsie temporale augmente-t-elle les risques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut augmenter le risque de dépression et d'anxiété chez les patients."
}
},
{
"@type": "Question",
"name": "Les crises peuvent-elles être mortelles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans de rares cas, des crises peuvent entraîner des complications mortelles, comme SUDEP."
}
},
{
"@type": "Question",
"name": "Comment gérer les blessures liées aux crises ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est important de sécuriser l'environnement et d'apprendre les premiers secours."
}
},
{
"@type": "Question",
"name": "Les troubles cognitifs sont-ils fréquents ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de la mémoire et de l'attention peuvent survenir chez certains patients."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque connus ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, les traumatismes crâniens et les infections cérébrales sont des facteurs."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'épilepsie temporale ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'épilepsie temporale est plus fréquente chez les jeunes adultes et les personnes âgées."
}
},
{
"@type": "Question",
"name": "Les maladies neurologiques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme la sclérose en plaques peuvent augmenter le risque d'épilepsie."
}
},
{
"@type": "Question",
"name": "Le stress peut-il être un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut déclencher des crises chez les personnes prédisposées."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles causer l'épilepsie temporale ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections comme l'encéphalite peuvent provoquer des crises épileptiques."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 09/04/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
Department of Bioengineering, University of Pennsylvania, United States.
Publications dans "Épilepsie temporale" :
4 publications dans cette catégorie
Affiliations :
Department of Diagnostics and Applied Technology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy. Electronic address: annarita.giovagnoli@istituto-besta.it.
Publications dans "Épilepsie temporale" :
4 publications dans cette catégorie
Affiliations :
Centre for Microscopy, Characterisation, and Analysis, University of Western Australia, Nedlands, Australia.
Publications dans "Épilepsie temporale" :
4 publications dans cette catégorie
Affiliations :
Department of Epilepsy, UCL Queen Square Institute of Neurology, London, United Kingdom.
UCL/UCLH NIHR University College London Hospitals Biomedical Research Centre, London, United Kingdom.
Publications dans "Épilepsie temporale" :
3 publications dans cette catégorie
Affiliations :
Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Jefferson Comprehensive Epilepsy Center, Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA. Electronic address: aliasadipooya@yahoo.com.
Publications dans "Épilepsie temporale" :
3 publications dans cette catégorie
Affiliations :
Department of Diagnostics and Applied Technology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy.
Publications dans "Épilepsie temporale" :
3 publications dans cette catégorie
Affiliations :
Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA.
Publications dans "Épilepsie temporale" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Northwestern University, Feinberg School of Medicine, Neurological Testing Center, 251 East Huron Street, Galter Pavilion 7-104, Chicago, IL 60611, USA. Electronic address: s-schuele@northwestern.edu.
Publications dans "Épilepsie temporale" :
2 publications dans cette catégorie
Affiliations :
Department of Psychology, University of Lille, Lille, France; Epilepsy Unit, Neurosciences Department, Hôpital de la Pitié-Salpêtrière, Paris, France. Electronic address: severine.samson@univ-lille.fr.
Publications dans "Épilepsie temporale" :
2 publications dans cette catégorie
Affiliations :
Rehabilitation Unit, Neurosciences Department, Hôpital de la Pitié-Salpêtrière, Paris, France.
Publications dans "Épilepsie temporale" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Publications dans "Épilepsie temporale" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Department of Neurology, William S Middleton Veterans Administration Hospital, Madison, WI, USA.
Publications dans "Épilepsie temporale" :
2 publications dans cette catégorie
Affiliations :
Department of Diagnostics and Applied Technology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy.
Publications dans "Épilepsie temporale" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan Province, China.
Publications dans "Épilepsie temporale" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Dell Medical School, The University of Texas at Austin, Austin, Texas, USA.
Comprehensive Pediatric Epilepsy Center, Dell Children's Medical Center, Austin, Texas, USA.
Department of Pediatrics, Dell Medical School, University of Texas at Austin, Austin, Texas, USA.
Publications dans "Épilepsie temporale" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Dell Medical School, The University of Texas at Austin, Austin, Texas, USA.
Comprehensive Pediatric Epilepsy Center, Dell Children's Medical Center, Austin, Texas, USA.
Publications dans "Épilepsie temporale" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Dell Medical School, The University of Texas at Austin, Austin, Texas, USA.
Comprehensive Pediatric Epilepsy Center, Dell Children's Medical Center, Austin, Texas, USA.
Department of Pediatrics, Dell Medical School, University of Texas at Austin, Austin, Texas, USA.
Publications dans "Épilepsie temporale" :
2 publications dans cette catégorie
Affiliations :
LREN, Department for Clinical Neurosciences, CHUV, University of Lausanne, Mont Paisible 16, 1011, Lausanne, Switzerland.
Department for Clinical Neurosciences, HUG, University Hospitals and Faculty of Medicine, Geneva, Switzerland.
Publications dans "Épilepsie temporale" :
2 publications dans cette catégorie
Affiliations :
Berenson-Allen Center for Non-Invasive Brain Stimulation, Cognitive Neurology Department, Beth Israel Medical Center, Harvard Medical School, Boston, MA, USA.
Siena Brain Investigation and Neuromodulation Lab, Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
Publications dans "Épilepsie temporale" :
2 publications dans cette catégorie
Affiliations :
LREN, Department for Clinical Neurosciences, CHUV, University of Lausanne, Mont Paisible 16, 1011, Lausanne, Switzerland.
Publications dans "Épilepsie temporale" :
To review the current literature on the multiple types and uses of progestins in reproductive healthcare....
Progestins for contraceptive use are available in multiple forms, with the ongoing development of transdermal, intravaginal, and male contraception formulations. Noncontraceptive use of progestins oft...
Progestins have multiple uses in reproductive healthcare, including contraception, menstrual suppression, endometrial protection, and hormonal replacement therapy. The development of progestins for th...
Numerous studies have confirmed a strong association between progestins and meningiomas and the regression and/or stabilization of meningiomas after discontinuation of treatment. Osteomeningiomas repr...
Thirty-six patients (mean age 49.5 years) who presented with at least one progestin-related osteomeningioma (48 tumors total) were identified from a prospectively collected database of patients and ha...
For half of the 36 patients, treatment was prescribed for signs of hyperandrogenism, such as hirsutism, alopecia, or acne. Most lesions were spheno-orbital (35.4%) or frontal (31.2%). Although the tis...
These results show that while the soft intracranial part of progestin-related osteomeningioma tumor is the most likely to regress after treatment discontinuation, the bony part is more likely to incre...
To estimate trends in use and outcomes of progestin therapy for premenopausal patients with endometrial intraepithelial neoplasia....
The MarketScan Database was used to identify patients aged 18-50 years with endometrial intraepithelial neoplasia from 2008 to 2020. Primary treatment was classified as hysterectomy or progestin-based...
A total of 3,947 patients were identified. Hysterectomy was performed in 2,149 (54.4%); progestins were used in 1,798 (45.6%). Use of progestins increased from 44.2% in 2008 to 63.4% in 2020 ( P =.002...
The rate of conservative treatment with progestins in premenopausal individuals with endometrial intraepithelial neoplasia has increased over time, and among progestin users, progestin-releasing IUD u...
Although several studies suggest beneficial effects of low-dose estrogen-progestins (LEPs) and progestins on dysmenorrhea in Japanese women, the difference in efficacy between drugs remains unknown....
We identified studies by searching the MEDLINE, Cochrane Library, and ICHUSHI databases and included randomized controlled trials (RCTs) that used total dysmenorrhea score and visual analogue scale (V...
We identified 10 articles on eight RCTs and included seven drugs (six LEPs and one progestin, i.e., dienogest) and placebo in the analysis. Meta-analysis showed improvements in total dysmenorrhea scor...
We confirmed that LEPs and dienogest are effective for primary and secondary dysmenorrhea and suggest that continuous regimens may be more effective than cyclic regimens in improving outcomes....
Progestin based therapy is the preferred option for fertility-sparing treatment of reproductive-age women with preserved fertility in endometrial hyperplasia (EH) or early endometrial cancer (EEC). Ou...
We conducted a meta-analysis of randomized or non-randomized controlled trials by searching of PubMed, Embase, Web of science, and Cochrane database from inception to November 8, 2022. The results of ...
In the analysis of progestin administered systemically or locally, complete response (CR) was significantly higher in progestin plus metformin versus progestin alone in the EH group (pooled OR 2.08, 9...
For fertility-sparing management, compared to progestin alone, the outcomes of patients with endometrial hyperplasia and early endometrial cancer were more improved with progestin plus metformin becau...
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the effectiveness, safety, and side effects associated with the usage of different treatments for un...
Gestodene (GES), altrenogest (ALT), and medroxyprogesterone acetate (MPA) are three potent synthetic progestins detected in agricultural soils; however, their biotransformation outcomes in soils remai...
Endometriosis is a complex chronic disease that affects approximately 10% of women of reproductive age worldwide and commonly presents with pelvic pain and infertility....
A systematic review of the literature was carried out using the databases Pubmed, Scopus, Cochrane and ClinicalTrials.gov in women with a confirmed laparoscopic diagnosis of endometriosis receiving pr...
Eighteen studies were included in the meta-analysis. Progestins improved painful symptoms compared to placebo (SMD = -0.61, 95% CI (-0.77, -0.45), P < 0.00001) with no comparable differences between t...
The meta-analysis revealed that pain improvement significantly increased with the use of progestins with low adverse effects....
PROSPERO CRD42021285026....
Altrenogest (ALT), drospirenone (DRO), and melengestrol acetate (MLA) are three highly potent synthetic progestins that can be released into agricultural soils, while their fate in soil minerals remai...
Synthetic progestins are micropollutants of special concern, due to their growing use in human and veterinary therapies and their risks to aquatic life. Currently, there is a lack of environmental inf...